| Kathryn Rosenblatt, MD | |
|
1800 Orleans St, Baltimore, MD 21287-0010 | |
| (410) 955-7461 | |
| (410) 614-7903 |
| Full Name | Kathryn Rosenblatt |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 1800 Orleans St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003132804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D77800 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Howard County General Hospital | Columbia, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
In the last several years, targeted therapies - drugs that directly impact specific genes and proteins involved in the progression of cancer - have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin cancer. Now, researchers at The Wistar Institute have discovered one way in which melanoma becomes resistant to a particular form of targeted therapy, and understanding this phenomenon may lead to a new melanoma target or prompt new designs of these treatments.
DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical® technologies and delivering related services for the clinical trials industry, today introduced the next generation clinical trial management system, UX CTMS 360.
Cubist Pharmaceuticals, Inc. a leading acute care therapeutics company, announced today the signing of a definitive agreement under which Cubist has agreed to acquire privately held Calixa Therapeutics Inc., a biopharmaceutical company focused on the development of novel antibiotics that address the expanding problem of multi-drug resistant Gram-negative pathogens.
The Pacific Meso Center at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest.
› Verified 1 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
In the last several years, targeted therapies - drugs that directly impact specific genes and proteins involved in the progression of cancer - have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin cancer. Now, researchers at The Wistar Institute have discovered one way in which melanoma becomes resistant to a particular form of targeted therapy, and understanding this phenomenon may lead to a new melanoma target or prompt new designs of these treatments.
DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical® technologies and delivering related services for the clinical trials industry, today introduced the next generation clinical trial management system, UX CTMS 360.
Cubist Pharmaceuticals, Inc. a leading acute care therapeutics company, announced today the signing of a definitive agreement under which Cubist has agreed to acquire privately held Calixa Therapeutics Inc., a biopharmaceutical company focused on the development of novel antibiotics that address the expanding problem of multi-drug resistant Gram-negative pathogens.
The Pacific Meso Center at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Rosenblatt, MD 9910 Franklin Square Dr Ste 2110, Baltimore, MD 21236-4902 Ph: (410) 933-6423 | Kathryn Rosenblatt, MD 1800 Orleans St, Baltimore, MD 21287-0010 Ph: (410) 955-7461 |
News Archive
In the last several years, targeted therapies - drugs that directly impact specific genes and proteins involved in the progression of cancer - have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin cancer. Now, researchers at The Wistar Institute have discovered one way in which melanoma becomes resistant to a particular form of targeted therapy, and understanding this phenomenon may lead to a new melanoma target or prompt new designs of these treatments.
DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical® technologies and delivering related services for the clinical trials industry, today introduced the next generation clinical trial management system, UX CTMS 360.
Cubist Pharmaceuticals, Inc. a leading acute care therapeutics company, announced today the signing of a definitive agreement under which Cubist has agreed to acquire privately held Calixa Therapeutics Inc., a biopharmaceutical company focused on the development of novel antibiotics that address the expanding problem of multi-drug resistant Gram-negative pathogens.
The Pacific Meso Center at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest.
› Verified 1 days ago
Dr. Tiffani Danielle Pittman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5601 Loch Raven Blvd, Baltimore, MD 21239 Phone: 443-444-4863 Fax: 443-444-4997 | |
Aaron Sachs, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 22 S Greene St # S11c, University Of Maryland Department Of Anesthesia, Baltimore, MD 21201 Phone: 410-328-1239 | |
Dr. Mohamed Ehab Ramadan Mohamed Ramadan, MBBCH, MSC, PHD Anesthesiology Medicare: Medicare Enrolled Practice Location: 600 North Wolfe Street, Nelson 2-131, Baltimore, MD 21287 Phone: 410-955-1818 | |
Lynette Mark, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6353 | |
Charles Lin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 Canton Ave, Baltimore, MD 21229 Phone: 410-368-3045 Fax: 410-951-4009 | |
Dr. Jasjit B Atwal, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St, Suite 300 6th Fl, Baltimore, MD 21201 Phone: 410-328-6720 Fax: 410-328-1674 |